184 related articles for article (PubMed ID: 24103533)
1. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women.
Duhan N; Madaan S; Sen J
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):329-32. PubMed ID: 24103533
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.
Parsanezhad ME; Azmoon M; Alborzi S; Rajaeefard A; Zarei A; Kazerooni T; Frank V; Schmidt EH
Fertil Steril; 2010 Jan; 93(1):192-8. PubMed ID: 19135657
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic uterine leiomyoma with letrozole.
Gurates B; Parmaksiz C; Kilic G; Celik H; Kumru S; Simsek M
Reprod Biomed Online; 2008 Oct; 17(4):569-74. PubMed ID: 18854113
[TBL] [Abstract][Full Text] [Related]
4. Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
Sayyah-Melli M; Mobasseri M; Gharabaghi PM; Ouladsahebmadarek E; Rahmani V
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():257-264. PubMed ID: 28076829
[TBL] [Abstract][Full Text] [Related]
5. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study.
Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912
[TBL] [Abstract][Full Text] [Related]
6. Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients.
Hilário SG; Bozzini N; Borsari R; Baracat EC
Fertil Steril; 2009 Jan; 91(1):240-3. PubMed ID: 18249392
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitors for uterine fibroids.
Song H; Lu D; Navaratnam K; Shi G
Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
[TBL] [Abstract][Full Text] [Related]
8. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study.
Leone Roberti Maggiore U; Scala C; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():157-62. PubMed ID: 25150954
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
Verma A; Konje JC
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):112-5. PubMed ID: 19233536
[TBL] [Abstract][Full Text] [Related]
10. The effect of anastrazole on symptomatic uterine leiomyomata.
Varelas FK; Papanicolaou AN; Vavatsi-Christaki N; Makedos GA; Vlassis GD
Obstet Gynecol; 2007 Sep; 110(3):643-9. PubMed ID: 17766612
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
12. A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole.
Nasu K; Tsuno A; Takai N; Narahara H
Arch Gynecol Obstet; 2009 Feb; 279(2):255-7. PubMed ID: 18523791
[TBL] [Abstract][Full Text] [Related]
13. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
George S; Feng Y; Manola J; Nucci MR; Butrynski JE; Morgan JA; Ramaiya N; Quek R; Penson RT; Wagner AJ; Harmon D; Demetri GD; Krasner C
Cancer; 2014 Mar; 120(5):738-43. PubMed ID: 24222211
[TBL] [Abstract][Full Text] [Related]
15. Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study.
Brito LG; Candido-dos-Reis FJ; Magario FA; Sabino-de-Freitas MM
Ultrasound Obstet Gynecol; 2012 Jul; 40(1):119-20. PubMed ID: 22102490
[No Abstract] [Full Text] [Related]
16. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
Zurawin RK; Fischer JH; Amir L
J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
[TBL] [Abstract][Full Text] [Related]
17. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
18. [Role of medical treatment for symptomatic leiomyoma management in premenopausal women].
Koskas M; Chabbert-Buffet N; Douvier S; Huchon C; Paganelli E; Derrien J
J Gynecol Obstet Biol Reprod (Paris); 2011 Dec; 40(8):858-74. PubMed ID: 22071015
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial.
Badawy AM; Elnashar AM; Mosbah AA
Acta Obstet Gynecol Scand; 2012 Apr; 91(4):489-95. PubMed ID: 22229256
[TBL] [Abstract][Full Text] [Related]
20. Relationship of myoma cell size and menopausal status in small uterine leiomyomas.
Cramer SF; Marchetti C; Freedman J; Padela A
Arch Pathol Lab Med; 2000 Oct; 124(10):1448-53. PubMed ID: 11035573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]